- Home
- TELA vs CBUS Comparison
TELA vs CBUS Comparison
Compare TELA & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELA
- CBUS
- Stock Information
- Founded
- TELA 2012
- CBUS 2010
- Country
- TELA United States
- CBUS United States
- Employees
- TELA N/A
- CBUS N/A
- Industry
- TELA Medical/Dental Instruments
- CBUS Agricultural Chemicals
- Sector
- TELA Health Care
- CBUS Industrials
- Exchange
- TELA Nasdaq
- CBUS Nasdaq
- Market Cap
- TELA 104.0M
- CBUS 120.1M
- IPO Year
- TELA 2019
- CBUS 2017
- Fundamental
- Price
- TELA $2.72
- CBUS $2.08
- Analyst Decision
- TELA Strong Buy
- CBUS Strong Buy
- Analyst Count
- TELA 4
- CBUS 3
- Target Price
- TELA $9.25
- CBUS $22.17
- AVG Volume (30 Days)
- TELA 186.3K
- CBUS 129.2K
- Earning Date
- TELA 03-20-2025
- CBUS 03-20-2025
- Dividend Yield
- TELA N/A
- CBUS N/A
- EPS Growth
- TELA N/A
- CBUS N/A
- EPS
- TELA N/A
- CBUS N/A
- Revenue
- TELA $68,649,000.00
- CBUS $4,152,999.00
- Revenue This Year
- TELA $30.39
- CBUS $132.42
- Revenue Next Year
- TELA $25.51
- CBUS $97.96
- P/E Ratio
- TELA N/A
- CBUS N/A
- Revenue Growth
- TELA 29.34
- CBUS 449.34
- 52 Week Low
- TELA $2.30
- CBUS $2.05
- 52 Week High
- TELA $7.18
- CBUS $23.18
- Technical
- Relative Strength Index (RSI)
- TELA 50.00
- CBUS 31.98
- Support Level
- TELA $2.53
- CBUS $2.39
- Resistance Level
- TELA $2.96
- CBUS $2.67
- Average True Range (ATR)
- TELA 0.13
- CBUS 0.19
- MACD
- TELA 0.02
- CBUS -0.01
- Stochastic Oscillator
- TELA 44.19
- CBUS 4.62
About TELA TELA Bio Inc.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.